1,144 results on '"Furuta, Takahisa"'
Search Results
202. Educational Practices in which students established and amended their own self-evaluation scales on classroom rules
203. Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori.
204. Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients
205. High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy
206. Su1291 COLON CAPSULE ENDOSCOPY IS A USEFUL AND ACCEPTABLE TECHNIQUE FOR THE ASSESSMENT OF MUCOSAL INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION
207. Su1217 - Estimation of the Degree of Gastric Mucosal Atrophy before H. Pylori Eradication Based on Serum Pepsinogen after Eradication
208. Mo1921 - Prevalence of Ul97 Gene Mutations and Polymorphisms in Cytomegalovirus Colitis in Japan
209. Su1832 - Potential Role of Serum 1,25-Dihydroxy Vitamin D3 as a Novel Biomarker Representing Disease Activity in Ulcerative Colitis
210. Sa1976 - Cd44 Variant 8-10 Expression in Cancer Stem-Like Cells is Associated with Poor Prognosis in Esophagal Squamous Cell Carcinoma Treated with Chemomradiotherapy
211. Tu1303 - Vonoprazan, Potassium Conpetitive Acid Blocker, is Superior to Another Proton Pump Inhibitors as First-Line Triple Therapy for Helicobacter Pylori Eradication: A Systematic Review and Meta-Analysis
212. Tu1299 - Vonoprazan-Based Dual Therapy with Amoxicillin is as Effectve as the Triple Therapy for the Eradication of H. Pylori
213. Tu1300 - Comparison of Vonoprazan and High Doses of PPI as the Acid Inhibitor in the Rescue Therapy for Eradication of H. Pylori
214. Response to “CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan”
215. Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial
216. Drug-Drug Interaction Associated with Gastric Acid Inhibitor
217. Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy
218. Development of measurement scale for expressiveness (speech) in Japanese Language in elementary school
219. Effect of genotypic differences in interleukin-1 beta on gastric acid secretion in Japanese patients infected with Helicobacter pylori
220. Assessing educational effects of ICT in mathematics classes : ICT in students' discussions
221. Assessments of empirical validity of three classroom models : The effects of verbalization of ideas through conversation in small groups in mathematics classes
222. Microsatellite frameshift variants in SGO1of gastric cancer are not always associated with MSI status
223. The Role of viewpoint in the perception of mirror reversal
224. MBD4 frameshift mutation caused by DNA mismatch repair deficiency enhances cytotoxicity by trifluridine, an active antitumor agent of TAS-102, in colorectal cancer cells
225. Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype
226. Vonoprazan-Based Dual Therapy With Amoxicillin Is as Effective as the Triple Therapy for Eradication of H. pylori
227. Digoxin Attenuates Murine Experimental Colitis by Downregulating Th17-related Cytokines
228. Disease Duration of Ulcerative Colitis Affects the Correlation between Pge-Mum and Clinical or Endoscopic Score
229. Autoimmune Gastritis in Japan: A Study of 200 Patients at Multicenter Study
230. Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as First-Line Triple Therapy for Helicobacter Pylori Eradication: A Systematic Review and Meta-Analysis
231. A Randomized, Placebo-Controlled, Double-Blind Clinical Trial of the Japanese Herbal Medicine Rikkunshito for Patients with Functional Dyspepsia: The Dream Study
232. Effects of Dosing Strategy of Amoxicillin on Eradication Rates of Helicobacter Pylori with Amoxicillin-Based Triple Therapy
233. Acid Inhibition Attained by Concomitant Administration of Lafutidine with Vonoprazan with Reference to Serum Gastrin Levels
234. Patients with Autoimmune Gastritis are Sometimes Misdiagnosed to be Refractory to the Eradication Therapy for H. Pylori
235. Effect of Vonoprazan on the Anti-Platelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype
236. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer
237. Natural Course of Helicobacter pylori Infection in Japanese Hemodialysis Patients
238. Influence of low-dose proton pump inhibitors administered concomitantly or separately on the anti-platelet function of clopidogrel
239. Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients.
240. M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T‐cell proliferation
241. Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection withHelicobacter pyloriin Japan
242. 319 Gastric Acid Inhibition With Vonoprazan and Esomeprazole in Healthy Japanese Subjects: Complete Acid Inhibition Attained by Vonoprazan
243. 4 Efficacy of the Kyoto Gastritis Classification for Endoscopic Identification of Patients at High Risk for Gastric Cancer
244. Sa1379 Relationship Between Plasma Ghrelin Level and Helicobacter pylori Status and Gastric Mucosal atrophy in Hemodialysis Patients
245. Tu1334 Evaluation of the Accuracy of DK14-HP-001, a Novel H. pylori Stool Antigen Test, for the Diagnosis of H. pylori Infection
246. Su1126 Influence of the Cure Rate of Gastroesophageal Reflux Disease in Relation to CYP2C19 Genotype Among Different Kinds of Proton Pump Inhibitors
247. Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis
248. Tu1333 Dual Therapy With Vonoprazan and Amoxicillin Is as Effective as Standard PPI-Based Triple Therapy With Amoxicillin and Clarithromycin or Metronidazole in Japan
249. Sa1107 Optimal Eradication Regimen for Helicobacter pylori in Patients on Hemodialysis
250. Tu1344 Efficacy of Helicobacter pylori Eradication Treatment Under Condition of Rabeprazole 4-Times Daily Dosing for Metronidazole-Resistance Strain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.